✦ LIBER ✦

Imaging-Based Measures of Disease Progression in Clinical Trials of Disease-Modifying Drugs for Alzheimer Disease

✍ Scribed by Matthews, Brandy; Siemers, Eric R.; Mozley, P. David

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-cognitive outcomes in trials of dise

✍ D. Zekry; C.E. Graf; S.V. Giannelli; G. Gold; J.-P. Michel 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 288 KB

Measuring progression of Alzheimer's dis

✍ Clifford R. Jack 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Neuroimaging biomarkers for clinical tri

✍ Dickerson, Bradford C. ;Sperling, Reisa A. 📂 Article 📅 2005 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 273 KB

Topographical Markers of Alzheimer's Dis

✍ Jicha, Gregory 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Measurement of disease progression in Al

✍ Friedland, Robert P.; Horwitz, Barry; Koss, Elisabeth 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Lessons learned from nine clinical trial

✍ Kenneth D. Brandt; Steven A. Mazzuca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views